The efficacy and safety of ondansetron in the prophylaxis of cancer-chemotherapy induced nausea and vomiting in children
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in Clinical Oncology
- Vol. 5 (1) , 11-14
- https://doi.org/10.1016/s0936-6555(05)80686-7
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- 5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatment.Archives of Disease in Childhood, 1990
- Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiationClinical Oncology, 1990
- Antiemetic therapy for chemotherapy-induced vomiting: Metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine aloneThe Journal of Pediatrics, 1989
- Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy.Journal of Clinical Oncology, 1985
- Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapyThe Journal of Pediatrics, 1984